Couverture de Ep.02 Cell therapy in Solid Tumors

Ep.02 Cell therapy in Solid Tumors

Ep.02 Cell therapy in Solid Tumors

Écouter gratuitement

Voir les détails

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
Solid tumour cells often use receptors such as PDL1 to block killing from immune cells. In this episode of the Cell Therapy Podcast we talk with Sébastien Wälchli, senior scientist at the Section for Cellular Therapy, Radiumhospitalet in Oslo, Norway about ways to bypass this cancer cell defense and how to improve CAR T cell therapy using combinatorial CARs. We discuss two recent papers from Dr Wälchli’s group called ‘Built-in” PD-1 blocker to rescue NK-92 activity from PD-L1–mediated tumor escape mechanisms’ (link: https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.202100025R) in FASEB and ‘Combinatorial CAR design improves target restriction’ (link: https://www.jbc.org/article/S0021-9258(20)00106-4/fulltext) in JBC. Read more about professor Sébastien Wälchli and his research here: https://www.ous-research.no/home/cellulartherapy/Group+members+TR+Unit/8303.
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment